Related Experiment Video
Updated: Aug 21, 2026

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
Published on: January 29, 2014
Hyperuricemia and reticulocytopenia in association with autoimmune hemolytic anemia in two children
Wasil A Jastaniah1, Sheila L Pritchard, John K Wu
1Division of Pediatric Hematology/Oncology/Bone Marrow Transplantation, University of British Columbia and British Columbia's Children's Hospital, Vancouver, Canada.
Insights
Hyperuricemia can occur in children with autoimmune hemolytic anemia during hemolytic crises. Monitoring for high uric acid levels may explain reticulocytopenia and prevent further procedures.
Area of Science:
- Hematology
- Pediatrics
- Clinical Chemistry
Background:
- Autoimmune hemolytic anemia (AIHA) is a condition where the immune system attacks red blood cells.
- Reticulocytopenia, a decrease in young red blood cells, can complicate AIHA.
- Hyperuricemia, elevated uric acid levels, is a metabolic abnormality with various causes.
Observation:
- Two pediatric patients with AIHA and reticulocytopenia presented with hyperuricemia during hemolytic crises.
- The timing of hyperuricemia coincided with acute hemolytic episodes.
Findings:
- Destruction of nucleated red blood cell precursors by autoantibodies is a likely cause of hyperuricemia in this context.
- Hyperuricemia may be a marker of intense red blood cell destruction in AIHA.
Implications:
- Screening for hyperuricemia in patients with AIHA and reticulocytopenia is recommended.
- Identifying hyperuricemia could elucidate the cause of reticulocytopenia, potentially avoiding invasive bone marrow examinations.
- Prompt recognition and supportive therapy for hyperuricemia are crucial to prevent renal complications in affected children.
Abstract:
Hyperuricemia developed in 2 children with autoimmune hemolytic anemia with reticulocytopenia at a time of hemolytic crisis. One likely cause of hyperuricemia is the destruction of nucleated RBC precursors by autoantibodies. It is advised that patients with autoimmune hemolytic anemia with reticulocytopenia be examined for hyperuricemia. This might explain the reason for reticulocytopenia and might prevent unnecessary bone marrow procedures. When hyperuricemia is present, supportive therapy might be needed to prevent renal damage.
Related Concept Videos
Hypersensitivity Reactions: Cytolytic Reactions
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune system...